A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer
Novello, S., Besse, B., Felip, E., Barlesi, F., Mazieres, J., Zalcman, G., von Pawel, J., Reck, M., Cappuzzo, F., Ferry, D., Carcereny, E., Santoro, A., Garcia-Ribas, I., Scagliotti, G., Soria, J.-C.
Published in Annals of oncology (01.11.2014)
Published in Annals of oncology (01.11.2014)
Get full text
Journal Article
Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors
Mayordomo, J I, Rivera, F, Díaz-Puente, M T, Lianes, P, Colomer, R, López-Brea, M, López, E, Paz-Ares, L, Hitt, R, García-Ribas, I
Published in JNCI : Journal of the National Cancer Institute (07.06.1995)
Published in JNCI : Journal of the National Cancer Institute (07.06.1995)
Get more information
Journal Article
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
Carles, J, Esteban, E, Climent, M, Font, A, Gonzalez-Larriba, JL, Berrocal, A, Garcia-Ribas, I, Marfa, X, Fabregat, X, Albanell, J, Bellmunt, J
Published in Annals of oncology (01.08.2007)
Published in Annals of oncology (01.08.2007)
Get full text
Journal Article
256 (PB244): Phase 1 clinical trial of the anti-LLT1 antibody ZM008 as monotherapy and in combination with pembrolizumab in advanced solid tumor patients
Ghosh, M., Ribas, I. Garcia, Fuloria, J., Rivera, I. Rodriguez, Vandross, A., Tiwari, A., Dubey, A.K., Bhattacharjee, S., Manjunath, Y., Kashipathi, S., Mandal, T.
Published in European journal of cancer (1990) (01.10.2024)
Published in European journal of cancer (1990) (01.10.2024)
Get full text
Journal Article
227P Biomarkers for novel NK checkpoint inhibitor anti LLT1 antibody, ZM008: Patient transcriptome analysis
Madhusudhan, M.S., Garcia Ribas, I., Ghosh, M., Tiwari, A., Dubey, A., Bhattacharjee, S., Manjunath, Y., Kashipathi, S., Krishna, S., Mandal, T., Gnanasegaran, S., Rodrigues, G.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
406P Phase Ib safety and efficacy of nadunolimab/gemcitabine/carboplatin in mTNBC
Lopez-Tarruella Cobo, S., Stradella, A., Ortega, P. Tolosa, Antolín-Novoa, S., Eslava, M. Santisteban, Garcia-Corbacho, J., Guerrero Zotano, A.L., Borrego, M. Ruiz, Caffarel, M. Muñoz, Losic, N., Gyllenbäck, E. Jaensson, Skoog, P., Johansen Blanco, H., Soto-Castillo, J.J., Alva Bianchi, M., Rendo, C. Reboredo, Casas, M., Caparroso, N., Montes, S. Bezares, Ribas, I. Garcia
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
538P Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)
Awada, A.H., Zematis, M., Ochsenreither, S., Eefsen, R.L., Arnold, D., Cicenas, S., Yachnin, J., Pfeiffer, P., Paz-Ares, L., Jungels, C., Greil, R., Poulsen, L. Østergaard, Van Cutsem, E., Ribas, I. Garcia, Thorsson, L., Collignon, J.J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Gastrointestinal Events in Melanoma Patients Treated with Ipilimumab and Nivolumab
Irwin, D, Davis, BM, Bell, J, Galaznik, A, Garcia-Ribas, I
Published in Value in health (01.05.2018)
Published in Value in health (01.05.2018)
Get full text
Journal Article
PCN1 - Gastrointestinal Events in Melanoma Patients Treated with Ipilimumab and Nivolumab
Irwin, D, Davis, BM, Bell, J, Galaznik, A, Garcia-Ribas, I
Published in Value in health (01.05.2018)
Published in Value in health (01.05.2018)
Get full text
Journal Article
Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer
Awada, Ahmad, Ochsenreither, Sebastian, Eefsen, Rikke Loevendahl, Arnold, Dirk, Yachnin, Jeffrey, Pfeiffer, Per, Jungels, Christiane, Greil, Richard, Poulsen, Laurids, Van Cutsem, Eric, Thorsson, Lars, Svedman, Christer, Garcia-Ribas, Ignacio, Collignon, Joelle
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Get full text
Journal Article
Conference Proceeding
Phase I study of oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients (pts) with advanced solid tumors
Koolen, S., Witteveen, P. O., Garcia-Ribas, I., Callies, S., Andre, V., Kronemeijer, R. H., Nol, A., Beijnen, J. H., Voest, E. E., Schellens, J. H.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
A phase 1 study of a new therapeutic modality for the local treatment of bladder cancer: Intravesical gemcitabine plus concomitant external radiotherapy
Lopez, H., Foro-Arnalot, P., Gomez de Segura, G., Algara, M., Domenech, M., Garcia-Ribas, I., Palou, J.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Phase I study of bi-weekly pemetrexed (P) plus cisplatin (C) in patients with advanced cancer
Lopez-Martin, A., Paz-Ares, L., Calvo, E., Castellano, D., Valverde, C., Neciosup, S., Vilar, E., San Antonio, B., Garcia-Ribas, I., Cortes-Funes, H., Bellmunt, J.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Evaluation of the role of confirming responses in clinical trials in oncology
Perez-Gracia, J. L., Muñoz, M., Wu, J., Carrasco, E., Garcia-Ribas, I., Peiro, A., Blatter, J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Evaluation of the role of confirming responses in clinical trials in oncology
Perez-Gracia, J. L., Muñoz, M., Wu, J., Carrasco, E., Garcia-Ribas, I., Peiro, A., Blatter, J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Phase I study of high-dose bi-weekly gemcitabine at a constant rate infusion (CRI) without growth factor support in advanced solid tumors, including prior standard gemcitabine treated patients
Bellmunt, J., Trigo, J. M., Garcia-Ribas, I., Roca, J. M., Galtes, S., Perez-Romero, A., de la Cruz, J. J., Tabernero, J. M., Alba, E., Baselga, J.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Gene expression profiling (GEP) for the prediction of response to neoadjuvant paclitaxel and gemcitabine in breast cancer (BC). Preliminary results from a Phase II trial
Llombart-Cussac, A., Moreno-Bueno, G., Ruiz, A., Albanell, J., Mayordomo, J. I., Carñana, V., Guillem, V., Diaz-Uriarte, R., Palacios, J., Garcia-Ribas, I.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
Font, A., Esteban, E., Carles, J., Climent, M. A., Gonzalez-Larriba, J. L., Berrocal, A., Bellmunt, J., Garcia-Ribas, I., Marfa, X., Fabregat, X.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
Font, A., Esteban, E., Carles, J., Climent, M. A., Gonzalez-Larriba, J. L., Berrocal, A., Bellmunt, J., Garcia-Ribas, I., Marfa, X., Fabregat, X.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article